Inflammation, Diabetes, and Chronic Kidney Disease: Role of Aerobic Capacity

Table 2

Clinical Variables between groups.

	Diabetics (𝑛=11)	Nondiabetics (𝑛=28)	𝑃
Age (years)	60±13.7	53±13.9	0.126
Gender: male/female	10 M/1 F	13 M/15 F	0.011
BMI (Kg/m^2)	28±3.4	26±5.8	0.298
Central SBP (mm Hg)	117±19.5	124±19.3	0.344
Central DBP (mm Hg)	74±10.4	87±12.1	0.005
Central PP (mm Hg)	43±15.1	37±12.5	0.205
PWV (m/seg)	8.3±1.36	8.3±1.24	0.884
AIx (%)	21±14.1	28±13.6	0.124
VO2max (mL/kg/min)	23.3±7.08	27.9±8.09	0.099
CA-IMT L—m (mm)	0.8±0.17	0.78±0.202	0.328
CA-IMT L—mx (mm)	1.0±0.20	0.94±0.248	0.459
CA-IMT R—m (mm)	0.9±0.29	0.76±0.216	0.081
CA-IMT R—mx (mm)	1.1±0.28	0.92±0.258	0.112
Presence of atherosclerotic plaque (%)	54.5	35.7	0.383

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; PWV: pulse wave velocity; AIx: augmentation index; CA-IMT L—m: mean of left carotid intima-media thickness; CA-IMT L—mx: maximal of left carotid intima-media thickness; CA-IMT R—m: mean of right carotid intima-media thickness; CA-IMT R—mx: maximal of right carotid intima-media thickness.